BioSpace News Archive

Press Releases

Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease

March 2, 2026
·
7 min read
Press Releases

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 47% and Risk of Death by 35% for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

March 2, 2026
·
19 min read
Press Releases

ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

March 2, 2026
·
20 min read
Press Releases

KEYTRUDA® (pembrolizumab) Plus Paclitaxel With or Without Bevacizumab Significantly Improved Key Secondary Endpoint of Overall Survival (OS) Versus Paclitaxel With or Without Bevacizumab in Patients With Platinum-Resistant Recurrent Ovarian Cancer

March 2, 2026
·
19 min read
Press Releases

Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026

March 2, 2026
·
10 min read
Press Releases

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

March 2, 2026
·
8 min read
Press Releases

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

March 2, 2026
·
5 min read
Press Releases

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - February 27, 2026

March 2, 2026
·
4 min read
Press Releases

Median Technologies to present at the TD Cowen 46th Annual Health Care Conference

March 2, 2026
·
2 min read
Press Releases

ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026

March 2, 2026
·
1 min read